Aug
25

Yesterday I discussed the ongoing debate about potential changes to California’s work comp fee schedule.
In case my position was too subtle, I’ve got grave reservations about using RBRVS (Medicare) as the basis for a work comp physician fee schedule. That said, it looks like RBRVS will replace the current methodology, but there’s still a lot of tweaking to do before the move is finalized.
Today we’ll dive into facility costs, which look to be rising rapidly in the Golden State, driven in part by a loophole in the regs that allow double billing for spinal implants, along with consolidation in the hospital market and the attendent market power. This power is allowing hospitals to get ever-higher pricing in their negotiations with work comp network providers, which, in turn, is reducing ‘savings’ delivered by those networks to payers.
Here’s a quick review of the CA facility fee schedule and some of the nuances and effects thereof.
Inpatient
The Official Medical Fee Schedule (OMFS) for inpatient care is facility-specific, based on Medicare’s MS-DRG methodology plus a 20% multiplier. Thus, WC pays about 20% more than Medicare for inpatient services. The idea behind MS-DRGs was sound – pay hospitals more accurately based on better coding of comorbidities and complications.
In reality, costs have escalated under MS-DRGs as hospitals have gotten better at coding, leading to payments almost 5% higher than projected under the previous DRG methodology.
According to a study published in July of last year by RAND, the spinal implant pass-through results in additional costs of at least $60 million to the system, and that estimate was based on Medicare’s average payment for the devices. Anecdotally, it appears that many work comp payers are likely paying well above that level. Efforts are underway to address this issue, but in the meantime payers are paying much more than they should for these devices.
Additionally, it isn’t too much of a leap to think that this over-payment may drive additional unnecessary utilization, as unscrupulous providers seek to maximize their revenues by performing as many procedures as possible.
Ambulatory surgery
This has been a bone of contention (sorry) for some time for WC payers in California. The regs actually peg reimbursement to hospital fees, at the same 120% of Medicare, resulting in reimbursement that many view as excessive. Quite excessive. Regulators are looking to revise the regs, and many expect reimbursement to decline as a result.
The revision process is happening as you read this; the latest proposal calls for adjusting the ambulatory surgical center fee schedule by reducing the multiplier for ambulatory surgical center facility fees to 100% of the Medicare outpatient fee schedule, plus a 2% reimbursement for high cost outlier cases. (here’s the latest update.)
So, what’s the net?
I’d argue, as many have, that the work comp facility fee schedule is too high. In some other states this wouldn’t be too much of an issue, as most bills would be repriced to a network discount, negating the fee schedule problem (albeit not entirely).
Unfortunately for payers in California, hospitals’ negotiating power has grown to the point where they can often dictate terms to large group health payers, who have much more bargaining power than work comp networks. In many instances, networks are negotiating deals with hospitals that are not much better than fee schedule
The result? Of late we’re seeing payers’ facility costs climb by double digits, with little relief in sight.
So what to do?
Rather than look for discounts, look at underlying costs.
There are wide variations between and among facilities for the same services, and by comparing costs and outcomes, payers can identify facilities that, while they may not offer a ‘discount’ per se, offer a much lower price than a hospital that does promises a discount.
A good place to start is the Dartmouth Atlas where you can find cost and outcome data for specific hospitals.


Aug
24

California work comp – Part One, the fee schedule debate

There’s a lot going on in California’s workers comp system – medical costs zooming up and driving premium increases along the way, narcotic usage skyrocketing, a dramatic increase in scripts for medical foods and compounds, judges upholding controversial decisions, and momentous decisions re changes to the fee schedule. Add the continued news about rising hospital costs, and you’ve got more than enough activity to keep anyone busy.
We can’t cover all the issues here, so a summary will have to suffice – promise to dig deeper into a few later this week and into next.
First, the controversy over changing the workers comp fee schedule.
California does not currently use Medicare’s RBRVS methodology as the basis for its non-facility fee schedule, making CA the only fee schedule state to not use RBRVS.(the other states that don’t use UCR, and I’d argue they really don’t have ‘fee schedules’ in the true sense of the term). The state has been considering moving from its current methodology the Official Medical Fee Schedule, or OMFS) to RBRVS for several years, with considerable progress over the last couple of months.
Most recently, public hearings were held in Sacramento with various stakeholders asked to respond to the latest revisions to the suggested fee schedule, revisions that added an additional $52 million in projected physician payments. I’ll spare the details on the methodological discussions, which have to do with changing teh conversion factor, one of the components of the RBRVS pricing methodology. (workcompcentral.com posted on this August 18). The basic argument advanced by providers is, well, pretty basic – if you reduce reimbursement, there may well be an access problem as providers opt out of workers comp.
According to workcompcentral.com;
“Destie Overpeck, the DWC’s chief counsel, said she was encouraged that most of the providers in the audience seemed to support the division’s multiple conversion factor plan, or at least understood it was needed to smooth the transition to a new system.
Primary care physicians, occupational therapists and providers who bill under the “all other” category would generally see an increase in payments, Overpeck said. “They seem to be saying, ‘Hey, we understand it’s not as high as we want or would get with a single conversion factor, but if you lower the rate on surgeons too much they won’t be there anymore,” she said.”
There is some evidence that lower work comp reimbursement does impact provider participation. When Florida increased reimbursement over a decade ago, anecdotal reports indicated more surgeons started accepting work comp patients. A pretty solid research effort (albeit one specific to neurologists) presented at the meeting showed a strong correlation between reimbursement rates (as a percentage of RBRVS) and provider participation rates; according to the study, “G{eneral] M[edical] fee levels provide the highest correlation (90.7%) with neurologist willingness to accept workers’’ compensation patients.”
The study also noted “a modified RBRVS medical fee schedule set at 156% of Medicare for EM fees and 121% for all other fees (an often-discussed plan) would result in a neurologist WC participation rate of 12.0%, third lowest in the U.S.”
(A METHODOLOGY FOR PREDICTING PROVIDER PARTICIPATION IN WORKERS’’ COMPENSATION MEDICAL FEE SCHEDULES
STEVEN E. LEVINE, M.D., PH.D. AND RONALD N. KENT, M.D.)

Perhaps the key point was best made by Kent Spafford, CEO of OneCall Medical, the leading work comp imaging company. Spafford noted: “The California Workers’ Compensation Fee Schedule is designed to provide adequate compensation to providers, so they are willing to provide care to injured workers. It is not the vehicle to control costs. Any action relative to the fee schedule should be designed to induce current and future providers into the system and not disenfranchise the existing providers.”
Recognizing OneCall’s is keenly interested in the fee schedule as it bears directly on the company’s ability to profitably operate in the state, Spafford’s comments are nonetheless well worth consideration. Without reasonable access to care, disability durations may well increase, the quality of care decline, and system costs continue their current upward trend. Notably, access under the current OMFS is pretty good, with 90% of patients reporting ‘good access to quality care’; the access problems that did occur weren’t related to cost but to administrative hassles, language issues and UR delays. As access is good under the current system, one has to consider the possible benefits of reduced prices – for some providers and some services in light of possible decreased access.
Moreover, as I’ve discussed here on numerous occasions, price per service is but one of, and certainly not the most important, contributor to total cost. As we’ve seen with California’s revised drug fee schedule, cutting price often doesn’t reduce cost – in fact, total drug costs in CA went up – way up – after the fee schedule was slashed.
I’ll draw a distinction between physicians and hospitals; as I’ll discuss tomorrow, California’s hospital costs are high and trending higher, with no likely end in sight.
California’s Division of Workers Comp is working diligently to balance the cost:access equation. I’d suggest that a careful and thorough assessment of hospital costs may well indicate there are lots of dollars to be saved, dollars that won’t compromise access.


Aug
23

Defining work comp medical cost ‘savings’

In the course of my consulting practice, I see a lot of work comp medical bill review ‘savings’ reports. Over the last fourteen years (since founding Health Strategy Associates in 1996) I’ve collected, reviewed, and analyzed scores of savings reports from pretty much every vendor in the business – as well as many of the larger TPAs and insurers.
There’s some consistency in the business, but not near enough. That alone makes it hard to compare one vendor to another, much less benchmark one company’s performance against the industry.
Leaving that aside, there are a number of issues with most reports, issues that clients/insureds/policyholders would do well to consider when evaluating performance or comparing potential vendors.
1. Does the savings report include reductions below state fee schedule (SFS) and/or Usual Customary and Reasonable (UCR)? Many vendors don’t split out savings below SFS/UCR, instead lumping all reductions into one ‘overall’ category. This is either a) an oversight as any vendor should be willing and able to demonstrate their ability to reprice bills to comply with regulations, or b) a way to inflate savings so the naive buyer sees a bit percentage reduction and thinks the vendor’s doing a crackerjack job.
2. Does the savings report clearly identify the source of UCR data? There are several vendors out there that provide these data, and knowing which is important in evaluating performance.
3. How are savings percentages calculated? Do they include savings for duplicate bills or duplicate line items (they shouldn’t). Do they include all types of care, such as pharmacy and imaging? In many instances these services are outsourced to specialists, requiring the customer to combine results to get an overall figure.
4. For pharmacy, savings should be reported using AWP as the benchmark – if the vendor wants to include SFS, that’s fine, but AWP (and make sure they define the source) is the universal standard.
5. How is network penetration calculated? Is the basis the number of bills or dollars? Dollars are preferred, but may skew the numbers higher than number of bills, as network penetration tends to be higher for facilities (which have higher average bill charges).
6. Over time, have you seen a decrease in fee schedule reductions and an increase in so-called ‘nurse review’ or ‘bill audit’ or ‘professional review’ savings? Hint – if these are billed separately, there’s often an inherent motivation on the part of the vendor to lowball SFS reductions in favor of these ‘other’ reductions.
7. Semantics and definitions. Make sure there’s a clear and complete understanding of each and every term, including such seemingly-obvious ones as ‘bill’ – can be a ‘staple’, a single page, a date of service, or ‘up to x lines’.
What does this mean to you?
There’s lots more to this, but the message should be clear – don’t assume you understand the report, ask lots of questions, consider how the vendor gets paid, and don’t hesitate to ask the vendor to revise the report to give you the information you need the way you want to see it.
After all, you’re the customer.


Aug
20

Work comp claims systems – the state of the industry

It’s hard to overstate the importance of the claims IT system in workers comp.
Systems directly, and materially, affect: productivity; compliance; claimant and policyholder satisfaction; medical costs; litigation rates, expenses, and outcomes; administrative expense (both unallocated and allocated); claims cost; employee retention and satisfaction; and ultimately growth, revenues, and profitability.
To date there hasn’t been a comprehensive survey of claims systems providing insights and data on features, trends, user satisfaction, key attributes, cost, flexibility, connectivity, issues and problems.
That’s about to change.
Next month Health Strategy Associates will conduct the First Annual Survey of Workers Comp Claims Systems, gathering input from all stakeholders including IT executives, claims executives, managers, and desk adjusters. The results of the survey will be available early in the fourth quarter, with an executive summary available at no cost to interested parties.
Management responses will be gathered in a structured telephonic interview format, while an online survey instrument will be used to gather responses from desk-level experts. Input from the two groups will be compared and contrasted, and we’re betting there are areas where the folks ‘on the front lines’ see things a bit differently than the people ‘in the management suite’.
Sandy Blunt, former COO of the Ohio state workers comp fund and former CEO of the North Dakota state fund, is running the project, and we couldn’t have a better leader. Sandy’s been intimately involved identifying requirements, selecting systems, comparing vendors, assessing performance, and designing workflows. His leadership will ensure the Survey is as practical as it is timely.
If you are interested in participating in the survey, send an email to Sandy at SBluntAThealthstrategyassocDOTcom.
Participants will receive a detailed version of the Survey Report.
We anticipate this will become an annual Survey, one of the series of Surveys conducted by Health Strategy Associates as we continue to help work comp payers, providers, and stakeholders make more informed decisions.


Aug
19

Implementing Health Reform – Health Wonk Review reports

Now that health reform is the law of the land, the focus has turned to implementing the law itself. As anyone knows, the real work, and the real impact, is in the details, the definitions, the requirements and operating guidelines.
And that’s what this edition of HWR is all about.
Fundamentals
Let’s begin this edition of HWR with a quick review of the fundamentals – starting with Tinker Ready’s reminder that “All health care is local.” Actually she’s channelling Atul Gawande in her report on his talk at the National Quality Colloquium this week. Gawande’s summary of why that’s the case is a very helpful reminder as we contemplate implementing reform.
My contribution to this edition asks the rather uncomfortable question “Managing health care costs – whose job is it?” WIth health plan associations whining about the lack of cost controls in the reform bill, one has to ask – exactly what function do health plans perform? If they’re asking the government to control costs, what is their purpose?
Friend and colleague Gary Anderberg is guest-posting over at Workers Comp Insider this biweek; Gary’s post is similar to Tinker’s in that his focuses on health insurance, and the services covered by insurance, are really ‘risk management tools’ to help maximize productivity. True True True, and a wonder more don’t think the same way…
On the “Good News’ front,“Congratulations If You Were Born Between 1952 and 1964” takes a look at the recently released report that shows health reform just extended the financial solvency of the Medicare Part A Trust Fund by 12 years. Brad Wright also stresses that we’re not out of the woods with the cost problem–2029 isn’t that far away–and we need to realize that this isn’t a problem we can solve, as much as it’s a tension that we have to figure out how to navigate.
In that vein, the always-insightful Jason Shafrin tells us the real story re the impact of reform on state budgets – not too good, but not too bad, either.
Reactions to reform
The opposition to reform continues to make its case; Anthony Wright documents the ongoing efforts by Anthem Blue Cross of California to stop California’s health insurance exchange. Anthony opines Anthem’s actions “should be a clarion call for California consumers about why we need to advance these bills, this year.”
In a related post, Roy Poses digs deep into Wellpoint’s rate increases, and finds out that the employee tasked with announcing the increases had serious concerns, concerns that may have led to her termination. As always, Roy finds the truth and does some of the best reporting in the blogosphere.
These last two stories are particularly important, because as Aaron Carroll warns us, insurance companies are very good at what they do. Which in this instance is risk selection. Talking in this case about Medicare HMO enrollment, Carroll elaborates:
“Somehow the private insurance HMOs figured out a way to get the healthy people to jump ship out of the another plan into theirs!
Not only that, but people who left the (private) HMOs and went back to the (public) Medicare used 180% more care after leaving than the people who stayed. Somehow the private insurance HMOs figured out a way to convince the sicker people to jump ship back to the public plans.”
Jaan Sidorov notes that “the odds against prevailing against a Presidential veto are..questionable and the waste of political energy would be atrocious.” But Jaan does think that the bill can be improved, and offers serious ways opponents should move.
The always -informed and -informing Maggie Mahar thinks the liberals/progressives who are hoping the anti-reform folks succeed (as it will usher in a single payer system) are basing their hopes on faulty assumptions, namely that Americans will like a Medicare-for-all plan. Maggie notes “A great many Americans have employer-based insurance that they like–particularly if they work for large companies. They don’t want to give it up for an unknown government plan.”
Maggie adds: “we’re all lucky that large companies are covering so many people with benefits that are, on average, rich and comprehensive.”
EHR, benefits, and babies
One of the keys to health reform is widespread adoption of Electronic Health Records; David Blumenthal and Dr Don Berwick (yes, the same Don Berwick who runs CMS) document the significant progress being made in that direction, emphasizing the new regs on ‘meaningful use’. Anyone remotely involved in EHR should read their post…
But before we adopt those EHRs, make sure to shred the patient records – or suffer the consequences described by David Harlow.
Implementation is all about the details – and there are bazillions of them, all critically important to those directly impacted. Jay talks about maternity coverage, and the absence of clarity about same in Colorado – even though all plans are supposed to provide coverage as of 1/1/2011…
Ryan opines that health plans authorized by the Feds should cover birth control, but only because we own the consequences if we don’t.
All carrot and no stick – Innovation in insurance – oxymoronic to some, just plan moronic to others (sorry, couldn’t resist). Our old friend and colleage David Williams writes about the problems realizing the potential of Value-Based insurance Design, noting “in practice most VBID programs encourage the use of high value services but don’t discourage the use of low value services.”
Important in their own way
Kinda-but-not-really related is this piece from Adam Fein of DrugChannels, who broke the story about CMS’s quest for a vendor to survey retail prices, payment, and utilization rates for pharmacy – as well as wholesale pricing. Could this lead to a substitute for AWP? Dare we hope?
Joanne Kenen reminds us why the ER is no place for palliative care, providing insights into what happens there – and more importantly – why.
John Goodman calls Medicaid “the most abusive health plan of all” in his post. Goodman bases his claim on states revising Medicaid enrollment and eligibility requirements, calling them ‘rescissions’. Ed. note – the reason most of these folks lost their coverage is the states where they lived ran out of money to fund Medicaid. Tax increases would’ve solved that ‘problem’…
Finally, over at InsureBlog, Mike Feehan says health plans should keep their reserves, no matter what Consumers’ Union thinks.


Aug
18

Medical foods and workers comp

The good folks at CWCI just published a research report (The Cost and Utilization of Compound Drugs, Convenience Packs and Medical Foods in California WC) documenting the rise in spend on medical foods, repackaged drugs, and compound drugs from 2006 – 2009; the highlight is these categories accounted for almost 12% of drug spend in California in Q1 2009.
A couple of the findings that jumped out at me…
– the average amount paid per compound drug as $728 in Q1 2009.
– medical food reimbursement hit $233 per script that quarter
– a new category, ‘co-packs’ has emerged as a significant therapy; these are combinations of drugs with medical foods dispensed as a single unit.
The story of drug costs and attempts to address same in California is fascinating, with lessons aplenty for regulators and payers.
– A drastic reduction in the fee schedule was followed by explosive growth in repackaged drugs.
– Regulatory changes finally addressed that issue, but meanwhile the use of narcotic opioids increased six-fold, likely negatively impacting disability duration as well as increasing cost.
– New entrants into the therapeutic armamentarium, entrants that are foreign to many adjusters, case managers, and work comp execs alike, are growing in importance, requiring regulators and payers alike to understand their impact and develop policies for coverage and reimbursement.
The list of medical foods includes Theramine, Gabadone, Sentra, Apptrim, Trepadone, and others, with Theramine (pain) and Sentra (sleep aid) accounting for over half of the volume in California. Medical foods are pretty new to me; according to the Orphan Drug Act (1988 Amendment), a medical food is “a food which is formulated to be consumed or administered enterally (orally) under the supervision of a physician, and which is intended for specific dietary management of a disease or condition for which distinctive nutritional requirements, based on recognized scientific principles, are established by medical evaluation.”
I’m no pharmacist or clinician, and am certainly not able to comment on the efficacy of medical foods or specific medications. For a primer on medical foods, click here.
There does appear to be evidence supporting the use of medical foods for treatment of pain, osteoarthritis, and other conditions, with one medical food, Limbrel, the subject of large, double-blind, placebo-controlled clinical studies in the United States and Japan. According to one source, “Limbrel administration has resulted in statistically significant improvement in all primary clinical endpoints (functional mobility, functional stiffness and functional joint discomfort).”
What does this mean for you?
If your P&T Committee hasn’t looked at medical foods yet, you may want to add it to the agenda for the next meeting. It is highly likely we’re going to see more of these scripts, and far better to be ready than to have your adjusters making decisions completely unprepared.


Aug
17

The cost of forgoing care

A new report documents the impact of the recession on the health care system, and for many Americans, the news is proof of what they know all too well – higher deductibles and copays are reducing their ability to access care.
The report [fee req] does not document whether the forgone care would have been necessary/appropriate/supported by evidence-based guidelines, and it is likely some of the forgone care was unnecessary. That said, it’s only ‘some’, and it is highly likely Americans with slimmer benefits, or no benefits at all, are skipping visits, medications, therapies, and operations that will over the long term will have very serious implications.
According to a piece in the NYTimes, the researchers reported “We find strong evidence that the economic crisis — manifested in job and wealth losses — has led to reductions in the use of routine medical care.” 26.5 percent of respondents reported reducing their use of routine medical care since the start of the global economic crisis in 2007.
The report adds more weight to the increasing evidence that the recession, coupled with the unique American health insurance system, has had a significant impact on Americans’ ability to access care.
The importance of primary care in prevention is well documented; [opens pdf] timely use of primary care tends to reduce the need for interventional procedures such as CABG, thereby reducing cost and improving long term quality of life. Delaying or forgoing primary care will likely have the opposite effect, increasing future health care costs.
Impact on workers comp
Over the short term, this ‘side effect’ of the recession will likely increase work comp costs
and extend disability duration, as more injured workers will have poor health status due to forgone care. If diabetics aren’t controlling their blood sugar, asthma sufferers have more acute episodes, and hypertensives are taking their meds every other day, it is going to be more difficult, costly, and time-consuming to help these claimants recover functionality.
Over the long term, health reform will reduce work comp costs as many more individuals will have coverage. But until 2015 (or so), we won’t see this positive influence.


Aug
16

Managing health care costs – whose job is it?

We’re learning a lot from Massachusett’s experiment in universal coverage – and some of the lessons are rather enlightening.
Take this one.
According to Bestwire, Lora Pellegrini, president of the Massachusetts Association of Health Plans, said something along the lines of “That’s the problem with the new U.S. health care reform law… it offers millions of uninsured Americans access to health insurance but doesn’t address underlying medical costs, which are contributing to costly premiums.” [not a direct quote]
Wait.
Isn’t that your job? In return for getting millions of new members, aren’t health plans supposed to figure out how to manage care and control costs?
If health plans rely on the government to help control costs, exactly what value do they deliver?

In fairness, Ms Pelligrini noted the market share of some provider groups is a significant factor in insurers’ inability to negotiate favorable rates. There’s no question negotiating power has shifted back towards providers, and that shift is contributing to higher costs for health plans.
Doesn’t seem to be hurting profits, though; the industry is enjoying a stellar 17.4% return on equity after seven publicly traded health plans reported earnings above expectations.
Try as I might to sympathize with insurers, their complaints are besides the point.
Suppliers in any business seek to maximize profits. Smart buyers will figure out how to find more cost-effective suppliers, develop alternative supply chains, or in very tight supply markets even resort to vertical integration, setting up their own suppliers.
I see no reason health plans can’t do the same. There’s far too much ‘old thinking’ among health plans; they remain overly concerned with the size of their network directory, believing large provider networks are essential to success.
Clearly, nothing could be further from the case. Some health plans are beginning to experiment with smaller, more exclusive networks, and I have no doubt the lower costs will make them much more attractive than the ‘old school’ huge networks with high costs due to broad access. No, success will come to those payers who creatively figure out how to work closely with selected providers, establishing partnerships, paying fairly, sharing information, and providing feedback.
Otherwise they’re just administrators, and not very efficient ones at that. If health plans are going to rely on the government to control costs, what, precisely, are health plans for?


Aug
12

Health plan enrollment is up, but that’s just part of the story

Mark Farrah and Associates’ latest report indicates health plans enjoyed a nice bump in enrollment in Q1 2010 from the previous quarter, with the entire increase coming from ASO (large, administrative-services only plans that are sold to larger employers) business.
In fact, risk-based insurance plans (more commonly purchased by smaller employers) saw a significant decline in enrollment in Q1 of 0.6%, or 890,000 members. According to MFA’s report, ” WellPoint added 565,000 new ASO members in 1Q10, but lost 400,000 fully insured members. UnitedHealth saw gains in both segments.”
What’s happening here?
It’s no surprise that the economy has hammered employers small and large, but smaller employers are more ‘flexible’ when it comes to benefit plans. They can choose to drop or add coverage much more quickly and with fewer repercussions than big firms. In fact, large employers almost never drop their coverage, while the percentage of smaller employers offering health insurance has been shrinking steadily for years.
The actual decrease in employer coverage (at least as it appears in MFA’s highlights) is masked somewhat by increases in Medicare Advantage PFFS plans, which grew significantly for CIGNA; there’s much of the Medicare PFFS story still to be written as Coventry completes its exit and other health plans work thru their respective strategies.
Year over year, Medicare Advantage plans have seen significant growth, with membership up by 600,000 members, despite a drop in the number of insurers offering MA options.
Meanwhile, medical trend numbers are looking better, contributing significantly to the jump in profits enjoyed by most of the major health plans. Contributing to the increase in 2009 was a drop in pharmacy expense, which was somewhat offset by a 1.2 point increase in the percentage of medical expense paid to hospitals.
Ok, so net it out.
Health plans are continuing to restructure their books of business, winnowing out the unprofitable or potentially-unprofitable members, states, and coverage types. The nice bump in profits isn’t surprising, but the hard work is yet to begin.
That hard work is changing from a risk selection to care and cost management business.


Aug
10

California’s Senate will be considering AB 2779 today, a bill that would (among other things) require Prior Authorization of compound medications for work comp claimants. While there’s no question compound meds are a big issue, the bill would do nothing to solve the Golden State’s larger problem – out of control drug utilization.
(thanks to WorkCompCentral for the heads up)
Here’s the issue.
The work comp drug fee schedule in California is pegged to Medi-Cal, resulting in the lowest reimbursement for drugs in the nation (with the possible exception of WA).
Pharmacy Benefit Managers (PBMs) operate on the difference between what they pay the pharmacy and what their customers pay them. In California, that delta is tiny, if not negative. If PBMs don’t have any operating margin, they can’t afford to allocate clinical resources to deal with prior auth requirements; they’ll lose even more money in an effort to help their clients. That’s neither appropriate nor good for the long term health of the comp business in California.
To those who claim the low fee schedule hasn’t caused any problems, I’d suggest a thorough read of CWCI’s excellent discussion of the explosive growth of narcotic opioids among comp claimants. Here’s the brief takeaway – California slashed the work comp pharmacy fee schedule just about in half six years ago. Since that time, the number of scripts per claimant has increased 25% and costs per claimant are up 31% (CWCI stats). And that’s not the worst of it. Schedule II narcotics have gone from less than one percent of scripts to almost six percent, a six-fold increase.
But what does that have to do with a bill designed to attack one of the emerging cost drivers – compound meds? Isn’t the proverbial half a loaf better than no loaf at all?
No.
While the bill enables payers to deny compound meds for medical necessity (a relatively easy call, as I don’t know of any evidence-based guidelines that recommend compounded medications, PBMs simply can’t afford to develop the workflows, do the research, hire the clinical staff, and manage and monitor the intake/referral to the adjuster/approval-denial/appeal processes. This is a lot of work, requires careful planning and implementation, and must include clinical staffing – nurses, pharmacists, and in some cases perhaps physicians.
We’ve seen the impact of the low fee schedule on total costs – they’ve gone up. What we haven’t seen is the impact on injured workers – many more are now on narcotic opioids, with some undoubtedly suffering from all the complications linked to these potentially debilitating and addictive drugs.
AB 2779 piles more work on top of an already overburdened industry, while doing nothing to address the underlying problem.
A major step in the right direction would be for California to de-link the comp fee schedule from Medicaid. That would give PBMs the pricing stability they need to help their clients regain control over drug costs.
For a detailed discussion of Medicaid’s suitability for work comp drug pricing, click here.